Diagnosing and quantifying a common deficit in multiple sclerosis

Objective We present an objective and quantitative approach for diagnosing internuclear ophthalmoplegia (INO) in multiple sclerosis (MS). Methods A validated standardized infrared oculography protocol (DEMoNS [Demonstrate Eye Movement Networks with Saccades]) was used for quantifying prosaccades in patients with MS and healthy controls (HCs). The versional dysconjugacy index (VDI) was calculated, which describes the ratio between the abducting and adducting eye. The VDI was determined for peak velocity, peak acceleration, peak velocity divided by amplitude, and area under the curve (AUC) of the saccadic trajectory. We calculated the diagnostic accuracy for the several VDI parameters by a receiver operating characteristic analysis comparing HCs and patients with MS. The National Eye Institute Visual Function Questionnaire–25 was used to investigate vision-related quality of life of MS patients with INO. Results Two hundred ten patients with MS and 58 HCs were included. The highest diagnostic accuracy was achieved by the VDI AUC of 15° horizontal prosaccades. Based on a combined VDI AUC and peak velocity divided by amplitude detection, the prevalence of an INO in MS calculated to 34%. In the INO group, 35.2% of the patients with MS reported any complaints of double vision, compared to 18.4% in the non-INO group (p = 0.010). MS patients with an INO had a lower overall vision-related quality of life (median 89.9, interquartile range 12.8) compared to patients without an INO (median 91.8, interquartile range 9.3, p = 0.011). Conclusions This study provides an accurate quantitative and clinically relevant definition of an INO in MS. This infrared oculography-based INO standard will require prospective validation. The high prevalence of INO in MS provides an anatomically well described and accurately quantifiable model for treatment trials in MS.

[1]  F. Barkhof,et al.  Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis , 2015, Neurology.

[2]  R. Müri,et al.  Clinical and oculographic examinations of saccadic eye movements in the diagnosis of multiple sclerosis. , 1986, Archives of neurology.

[3]  M. Józefowicz-Korczynska,et al.  Identification of internuclear ophthalmoplegia signs in multiple sclerosis patients , 2008, Journal of Neurology.

[4]  C. Westall,et al.  Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients. , 2006, American journal of ophthalmology.

[5]  Mike P. Wattjes,et al.  The investigation of acute optic neuritis: a review and proposed protocol , 2014, Nature Reviews Neurology.

[6]  D. Zee,et al.  Accuracy of clinical detection of INO in MS , 2003, Neurology.

[7]  Frederik Barkhof,et al.  Increased default-mode network centrality in cognitively impaired multiple sclerosis patients , 2017, Neurology.

[8]  M. Maguire,et al.  Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite , 2003, Neurology.

[9]  Jeffrey A. Cohen,et al.  Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine , 2014, Neurology.

[10]  H. Collewijn,et al.  Binocular co‐ordination of human horizontal saccadic eye movements. , 1988, The Journal of physiology.

[11]  R. Leigh,et al.  Abnormal Eye Movements Predict Disability in MS: Two‐Year Follow‐Up , 2005, Annals of the New York Academy of Sciences.

[12]  H. Collewijn,et al.  Human ocular counterroll: assessment of static and dynamic properties from electromagnetic scleral coil recordings , 2004, Experimental Brain Research.

[13]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[14]  R. Leigh,et al.  Saccadic and Vestibular Abnormalities in Multiple Sclerosis , 2002 .

[15]  Claude Prablanc,et al.  Saccade metrics in multiple sclerosis: Versional velocity disconjugacy as the best clue? , 1991, Journal of the Neurological Sciences.

[16]  B. Uitdehaag,et al.  A rare cause for visual symptoms in multiple sclerosis: posterior internuclear ophthalmoplegia of Lutz, a historical misnomer , 2017, Journal of Neurology.

[17]  D. Robinson,et al.  A METHOD OF MEASURING EYE MOVEMENT USING A SCLERAL SEARCH COIL IN A MAGNETIC FIELD. , 1963, IEEE transactions on bio-medical engineering.

[18]  Muna Shakeeb Tawfiq Rating Neurological Impairment in Multiple Sclerosis , 2016 .

[19]  Teresa C. Frohman,et al.  A new measure of dysconjugacy in INO: the first-pass amplitude , 2003, Journal of the Neurological Sciences.

[20]  G. Salemi,et al.  Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity , 2005, Neurology.

[21]  B. Uitdehaag,et al.  Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial , 2019, CNS neuroscience & therapeutics.

[22]  R. Hays,et al.  Development of the 25-item National Eye Institute Visual Function Questionnaire. , 2001 .

[23]  Lublin Fd,et al.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .

[24]  H. Collewijn,et al.  Binocular saccadic eye movements in multiple sclerosis , 1997, Journal of the Neurological Sciences.

[25]  B. Troost,et al.  Velocity characteristics of normal human saccades. , 1974, Investigative ophthalmology.

[26]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[27]  J A Nij Bijvank,et al.  A standardized protocol for quantification of saccadic eye movements: DEMoNS , 2018, PloS one.

[28]  P. O'Suilleabhain,et al.  Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score , 2002, Journal of neurology, neurosurgery, and psychiatry.

[29]  Frederik Barkhof,et al.  Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. , 2016, Brain : a journal of neurology.

[30]  R. Müri,et al.  The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis. , 1985, Archives of neurology.

[31]  R. John Leigh,et al.  Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis , 2003, Journal of Neurology.

[32]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.